Galera Therapeutics, Inc.
At Close: 4:00 PM
After Market: 3:00 AM
GRTX Stock Price Graph
GRTX Stock Price Today
Galera Therapeutics, Inc. (GRTX) stock declined over 0.00% intraday to trade at $3.16 a share on NASDAQ. The stock opened with a gain of 1.27% at $3.20 and touched an intraday high of $3.29, falling 0.00% against the last close of $3.16. The Galera Therapeutics, Inc. in stock market went to a low of $3.14 during the session.
GRTX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
GRTX Stock Price History Chart
2 West Liberty BoulevardMalvern, PA 19355US
Contact #:610 725 1500
Sales or RevenueN/A
5Y Sales ChangeN/A
Fiscal Year EndsDec. 2022
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Frequently Asked Questions
What is the current Galera Therapeutics, Inc. (GRTX) stock price?
Galera Therapeutics, Inc. (NASDAQ: GRTX) stock price is $3.16 in the last trading session. During the trading session, GRTX stock reached the peak price of $3.29 while $3.14 was the lowest point it dropped to. The percentage change in GRTX stock occurred in the recent session was 0.00% while the dollar amount for the price change in GRTX stock was $0.00.
GRTX's industry and sector of operation?
The NASDAQ listed GRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Galera Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer.
Who are the executives of GRTX?
Ms. Judy Schnyder
Senior Vice President of Clinical Operations & Data Management
Ms. Andie Collier
Senior Vice President of Regulatory Affairs
Dr. J. Mel Sorensen M.D.
Chief Executive Officer, Pres & Director
Dr. Jon T. Holmlund M.D.
How GRTX did perform over past 52-week?
GRTX's closing price is 1.73% higher than its 52-week low of $1.12 where as its distance from 52-week high of $3.5 is -0.08%.
How many employees does GRTX have?
Number of GRTX employees currently stands at 31.00. GRTX operates from 2 West Liberty Boulevard</br>Malvern, PA 19355</br>US.
Link for GRTX official website?
Official Website of GRTX is: https://www.galeratx.com
How do I contact GRTX?
GRTX could be contacted at phone #610 725 1500 and can also be accessed through its website. GRTX operates from 2 West Liberty Boulevard</br>Malvern, PA 19355</br>US.
How many shares of GRTX are traded daily?
GRTX stock volume for the day was 366388.00 shares. The average number of GRTX shares traded daily for last 3 months was 796.52 Thousands.
What is the market cap of GRTX currently?
The market value of GRTX currently stands at $142.35 Million with its latest stock price at $3.16 and 35.42 Million of its shares outstanding.